SMAD4 and metabolic dysfunction-associated steatohepatitis: Qin et al. found that the expression of inflammatory markers, fibrotic markers, and lipogenic genes was significantly lower in the liver tissue of hepatocyte-specific Smad4-deficient NASH mice than that in wild-type mice [16].